Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
Support MFO
Donate through PayPal
Experimental Vaccine used on the Two Ebola Patients with Apparent Success
@JohnChisum 1. It is not a vaccine, it is a drug. 2. It is really only a drug in the FDA definition sense, not as a lay person would think of it; rather, it is an antiviral monoclonal antibody (in this case, probably a collection of them) produced by biotechnology, that binds to Ebola virus proteins and subsequently neutralize live virus. Think of the treatment as antiviral immunotherapy. 3. It is not an example of military research moving out into the public sphere, like a NASA invention. Military labs simply would not have these special capabilities. Most of this work is being done in the public/private research world, funded by money from the US Army.
Comments
OJ
1. It is not a vaccine, it is a drug.
2. It is really only a drug in the FDA definition sense, not as a lay person would think of it; rather, it is an antiviral monoclonal antibody (in this case, probably a collection of them) produced by biotechnology, that binds to Ebola virus proteins and subsequently neutralize live virus. Think of the treatment as antiviral immunotherapy.
3. It is not an example of military research moving out into the public sphere, like a NASA invention. Military labs simply would not have these special capabilities. Most of this work is being done in the public/private research world, funded by money from the US Army.